US FDA/CFSAN - BSE and Cosmetics: FDA Risk Assessment and Management Perspectives - Slide 27

US FDA/CFSAN - BSE and Cosmetics: FDA Risk Assessment and Management Perspectives December 7, 2006

US FDA/CFSAN

BSE and Cosmetics: FDA Risk Assessment and Management Perspectives

December 7, 2006

Industry Initiatives

CTFA Board Policy Statement on 'Mad Cow Disease' (April 20, 2001)
- Cosmetic products must not contain BSE-risk raw materials, as identified by WHO as SRMs.
- Suppliers to certify bovine-derived ingredients free of risk materials
- Tallow derivatives to be processed by methods that assure they are safe.

Slide 27 of 45

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45

Slide 27 of 45